A health care worker receives the Johnson & Johnson Covid-19 vaccine in Cape Town, South Africa, on February 17. The vaccine has been approved by South African Health Products Authority and is expected to only be given to health care workers. Photo: EPA-EFE A health care worker receives the Johnson & Johnson Covid-19 vaccine in Cape Town, South Africa, on February 17. The vaccine has been approved by South African Health Products Authority and is expected to only be given to health care workers. Photo: EPA-EFE
A health care worker receives the Johnson & Johnson Covid-19 vaccine in Cape Town, South Africa, on February 17. The vaccine has been approved by South African Health Products Authority and is expected to only be given to health care workers. Photo: EPA-EFE

Coronavirus: Sinovac claims good results against British and South African strains challenging vaccine makers

  • Vaccine makers prepare to develop improved booster shots to stay on top of emerging variants
  • Sinovac CEO says inactivated vaccines offer a broad spectrum of protection but the company did not show data backing its claim

Topic |   Coronavirus China
A health care worker receives the Johnson & Johnson Covid-19 vaccine in Cape Town, South Africa, on February 17. The vaccine has been approved by South African Health Products Authority and is expected to only be given to health care workers. Photo: EPA-EFE A health care worker receives the Johnson & Johnson Covid-19 vaccine in Cape Town, South Africa, on February 17. The vaccine has been approved by South African Health Products Authority and is expected to only be given to health care workers. Photo: EPA-EFE
A health care worker receives the Johnson & Johnson Covid-19 vaccine in Cape Town, South Africa, on February 17. The vaccine has been approved by South African Health Products Authority and is expected to only be given to health care workers. Photo: EPA-EFE
READ FULL ARTICLE